REFERENCES
- Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor binding protein (IGFBP) superfamily. Endocr Rev. 1999;6:761–787.
- Collet C, Candy J. How many insulin-like growth factor binding protein? Mol Cell Endocrinol. 1998;139:1–6.
- Emrick MA, Lee T, Starkey PJ, The gatekeeper residue controls autoactivation of ERK2 via a pathway of intramolecular connectivity. Proc Natl Acad Sci U S A. 2006;103:18101–18106.
- Formstecher E, Ramos JW, Fauquet M, PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell. 2001;1:239–250.
- Frommer M, McDonald LE, Millar DS, A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A. 1992;89:1827–1831.
- Campisi J. Suppressing cancer: the importance of being senescent. Science. 2005;309:886–887.
- Hartman SE, Bertone P, Nath AK, Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev. 2005;19:2953–2968.
- Hingorani SR, Jacobetz MA, Robertson GP, Suppression of BRAF(V599E) in human melanoma abrogates transformation. Cancer Res. 2003;63:5198–5202.
- Hoeflich KP, Gray DC, Eby MT, Oncogenic BRAF is required for tumor growth and maintenance in melanoma models. Cancer Res. 2006;66:999–1006.
- Hu SY, Chen ZX, Cen JN, The expression of IGFBP-rP1 in leukemia. Zhonghua Nei Ke Za Zhi. 2005;44:931–932.
- Heesch S, Schlee C, Neumann M, BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia. Leukemia. 2010;24:1429–1436.
- Heesch S, Bartram I, Neumann M, Expression of IGFBP7 in acute leukemia is regulated by DNA methylation. Cancer Sci. 2011;102:253–259.
- [Suggestion of diagnosis and treatment of acute myelocytic leukemia in childhood]. Subspecialty Group of Hematology Diseases, The Society of Pediatrics, Chinese Medical Association; Editorial Board, Chinese Journal of Pediatrics. Zhonghua Er Ke Za Zhi. 2006;44:877–878.
- Murphy M, Pyktt MJ, Harnish P, Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Differ. 1993;4:715–722.
- Ruan W, Xu E, Xu F, IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis. Cancer Biol Ther. 2007;6:354–359.
- Ma Y, Lu B, Ruan W, Tumor suppressor gene insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) induces senescence-like growth arrest in colorectal cancer cells. Exp Mol Pathol. 2008;85:141–145.
- Chen Y, Pacyna-Gengelbach M, Ye F, Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer. Pathology. 2007;211:431–438.
- Plymate SR, Haugk KH, Sprenger CC, Increase manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1. Oncogene. 2003;22:1024–1034.
- Chen RY, Chen HX, Lin JX, In-vivo transfection of pcDNA3.1-IGFBP7 inhibits melanoma growth in mice through apoptosis induction and VEGF downexpression. J Exp Clin Cancer Res. 2010;29:13–20.
- Vizioli MG, Sensi M, Miranda C, IGFBP7: an oncosuppressor gene in thyroid carcinogenesis. Oncogene. 2010;29:3835–3844.
- Landberg G, Ostlund H, Nielsen NH, Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors. Oncogene. 2001;20:3497–3505.
- Wajapeyee N, Serra RW, Zhu XC, Oncogenic BRAF Induces Senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 2008;132:363–374.
- Scurr LL, Pupo GM, Becker TM, IGFBP7 is not required for B-RAF-induced melanocyte senescence. Cell. 2010;141:717–727.
- Akaogi K, Sato J, Okabe Y, Synergistic growth stimulation of mouse fibroblasts by tumor-derived adhesion factor with insulin-like growth factors and insulin. Cell Growth Differ. 1996;7:1671–1677.
- Pen A, Moreno MJ, Durocher Y, Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-β signaling tumor cells induce IGFBP7 in endothelium. Oncogene. 2008;27:6834–6844.
- van Beijnum JR, Dings RP, Van Der Linden E, Gene expression of tumor angiogenesis dissected; specific targeting of colon cancer angiogenic vasculature. Blood. 2006;108:2339–2348.
- Akaogi K, Okabe Y, Sato J, Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells. Proc Natl Acad Sci U S A. 1996;93:8384–8389.
- Nagakubo D, Murai T, Tanaka T, A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines. J Immunol. 2003;171:553–561.
- Solito E, Romero IA, Marullo S, Annexin 1 binds to U937 monocytic cells and inhibits their adhesion to microvascular endothelium: involvement of the α4β1 integrin. J Immunol. 2000;165:1573–1581.